
GC16444
Rosiglitazone
Also known as 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Rosiglitazone is an orally active peroxisome proliferator-activated receptor gamma (PPARγ) selective agonist that selectively activates chimeras containing the PPARγ ligand-binding domain (LBD) but not PPARα and PPARδ with an EC50 of 60 nM and a Kd of 40nM
ChemicalCAS122320-73-4MW357.43FormulaC18H19N3O3S
- CAS number
- 122320-73-4
- Molecular weight
- 357.43
- Formula
- C18H19N3O3S
- Solubility
- 100mg/ml in DMSO
- InChIKey
- YASAKCUCGLMORW-UHFFFAOYSA-N
- Catalogue number
- GC16444
- Brand
- GLPBIO
Computed properties PubChem CID 77999 · XLogP 3.1 · TPSA 96.8 Ų · H-bond donors 1
- XLogP
- 3.1
- TPSA
- 96.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 7
- Heavy atoms
- 25
SMILES CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
Computed descriptors from PubChem (CID 77999), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il